Abbott, AbbVie settle U.S. case over TriCor marketing for $25 million

Abbott Laboratories and AbbVie Inc will pay $25 million to resolve allegations that Abbott paid kickbacks to doctors in exchange for them prescribing the cholesterol drug TriCor and promoted the medication for unapproved purposes.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news